The bio juniors like ONVO have to follow GOOG's compensation model. All senior management should take $1 in salary, the rest should be compensated by fixed amount of shares. Keith is a CTO at most and not qualified as a CEO. He can not even understand how capital market work, what do you think the likelihood of protecting existing shareholders, ZERO!
There are some discussion about the "Share Price Appreciation" exchange to replace NYSE and NASDAQ. These are the companies that focus on the growth of net cash inflows and share buybacks, KHC and MDLZ are good examples. If no cash inflows, the companies will figure out way to sell merchandises like mugs and T-Shirt like CSX to survive, equity financing always create share dilution. But, it will be fine if all management's comp tires with the stock performance.
Keith may be an expert in his biolab field and he is just an urban legend. He lost the confidence of investors on managing the direction of corporate finance. Until we find one more finance savvy, there is no sense to rush to buy this stock.
Hope this will help.
The notion here is that she is the only person can lead DD, no one else? What if she leaves, will DD be better off?
They covered all @ $3.5 by taking advantage of financial ignorance of this mgmt. Short @ $5 and cover all @ $3.5. Then long @ $3.6 again.
Tough time to get through this, once China and other recover their markets, we will have hope to climb over $100. The group of U$ bull is still in charge now, for how long? It may approach to the end @ $50/barrel on WTI. The dividend increase proves to me that there is a light in the end of the tunnel. Not ready to give up on COP just yet. The monthly DRIP is the best way to accumulate shares. $55 is a level to watch. Right now, it is a value play.
Sentiment: Strong Buy